title: FDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM.
mesh_terms: D026683:Advisory Committees; D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring; D002138:Calibration; D018795:Device Approval; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D016903:Drug Monitoring; D006801:Humans; D006943:Hyperglycemia / Q000175:diagnosis* / Q000517:prevention & control; D007003:Hypoglycemia / Q000139:chemically induced / Q000175:diagnosis* / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018670:Monitoring, Ambulatory / Q000009:adverse effects / Q000295:instrumentation*; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin